SIRT5 and colorectal carcinoma: SIRT5 modulates glutamine metabolism at the post-translational level in CRC, wherein SIRT5 silencing disrupted α-KG formation from glutamate, consequently hindering the entry of glutamine-derived metabolites into the TCA cycle, thereby impeding anabolic biosynthesis.